Nogo-B-IN-1 ((S,R)-4v) is a covalent inhibitor targeting Nogo-B. It suppresses osteosarcoma (OS) progression by inhibiting Nogo-B activity and the PI3K/AKT/NF-kappaB/Bcl-2 signaling pathways. Nogo-B-IN-1 hinders proliferation of OS 143B cells (IC50= 0.28 µM) and induces apoptosis. This compound is applicable for targeted OS research.
Target:
NF-kappaB|||Bcl-2 Family|||Akt|||Apoptosis|||PI3K
* VAT and and shipping costs not included. Errors and price changes excepted
